Advertisement

Advances in the Use of Growth Factors for Treatment of Disorders of Soft Tissues

  • Jaroslava HalperEmail author
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 802)

Abstract

Repair and healing of injured and diseased tendons have been traditionally fraught with apprehension and difficulties, and often lead to rather unsatisfactory results. The burgeoning research field of growth factors has opened new venues for treatment of tendon disorders and injuries, and possibly for treatment of disorders of the aorta and major arteries as well. Several chapters in this volume elucidate the role of transforming growth factor β in pathogenesis of several heritable disorders affecting soft tissues, such as aorta, cardiac valves, and tendons and ligaments. Several members of the bone morphogenetic group either have been approved by the FDA for treatment of non-healing fractures or have been undergoing intensive clinical and experimental testing for use in healing of bone fractures and tendon injuries. Because FGFs are involved in embryonic development of tendons and muscles among other tissues and organs the hope is that their testing would lead to the development of some new treatment strategies providing that we can control angiogenicity of these growth factors. The problem, or rather question regarding practical use of IGF-I in tendon repair is whether IGF-I acts independently or under the guidance of growth hormone. FGF2 or PDGF alone or in combination with IGF-I stimulated regeneration of periodontal ligament, a matter of importance in Marfan patients with periodontitis. In contrast, VEGF appears to have rather deleterious effect on experimental tendon healing, perhaps because of its angiogenic activity and stimulation of matrix metalloproteinases, proteases whose increased expression has been documented in a variety of ruptured tendons. Other modalities, such as local administration of platelet-rich plasma (PRP) and/or of mesenchymal stem cells have been explored extensively in tendon healing. Though treatment with PRP and mesenchymal stem cells has met with some success in horses (who experience a lot of tendon injuries and other tendon problems), the use of PRP and mesenchymal stem cells in people has been more problematic and requires more studies before PRP and mesenchymal stem cells can become reliable tools in management of soft tissue injuries and disorders.

Keywords

Tendon repair Transforming growth factor β (TGFβ) family Bone morphogenetic proteins (BMPs) Fibroblast growth factors (FGFs) Insulin-like growth factor I (FGF-I) Platelet-derived growth factor (PDGF) Vascular endothelial growth factor (VEGF) Platelet-rich plasma (PRP) Stem cells 

References

  1. 1.
    Södersten F, Hultenby K, Heinegård D, Johnston C, Ekman S (2013) Immunolocalization of collagens (I and III) and cartilage oligomeric matrix protein (COMP) in the normal and injured equine superficial digital flexor tendon. Connect Tissue Res 54:62–69PubMedCentralPubMedGoogle Scholar
  2. 2.
    Jones GC, Corps AN, Pennington CJ, Clark IM, Edwards DR, Bradley MM, Hazleman BL, Riley GP (2006) Expression profiling of metalloproteinases and tissue inhibitors of metalloproteinases in normal and degenerate human Achilles tendon. Arthritis Rheumatol 54:832–842Google Scholar
  3. 3.
    Woo SL-Y, Hildebrand K, Watanabe N, Fenwick JA, Papageorgiou CD, Wang JH-C (1999) Tissue engineering of ligament and tendon healing. Clin Orthop Relat Res 357S:S312–S323Google Scholar
  4. 4.
    Greenough CG (1996) The effect of pulsed electromagnetic fields on flexor tendon healing in the rabbit. J Hand Surg 21:808–812Google Scholar
  5. 5.
    Noguchi M, Seiler JG, Gelberman RH, Sofranko RA, Woo SL-Y (1993) In vitro biomechanical analysis of suture methods for flexor tendon repair. J Orthop Res 11:603–611PubMedGoogle Scholar
  6. 6.
    Suda N, Shiga M, Ganburged G, Moriyama K (2009) Marfan syndrome and its disorder in periodontal tissues. J Exp Zool (Mol Dev Evol) 312B:503–509Google Scholar
  7. 7.
    Ingraham JM, Hauck RM, Ehrlich HP (2003) Is the tendon embryogenesis process resurrected during tendon healing? Plast Reconstr Surg 112:844–854PubMedGoogle Scholar
  8. 8.
    Manske PR, Gelberman RH, Lesker PA (1985) Flexor tendon healing. Hand Clin 1:25–34PubMedGoogle Scholar
  9. 9.
    Mast BA, Haynes JH, Krummel TM, Diegelmann RF, Cohen IK (1992) In vivo degradation of fetal wound hyaluronic acid results in increased fibroplasia, collagen deposition, and neovascularization. Plast Reconstr Surg 89:503–509PubMedGoogle Scholar
  10. 10.
    Chen CH, Liu HW, Tsai CL, Yu CM, Lin IH, Hsiue GH (2008) Photoencapsulation of bone morphogenetic protein-2 and periosteal progenitor cells improve tendon graft healing in a bone tunnel. Am J Sports Med 36:461–472PubMedGoogle Scholar
  11. 11.
    Mass DP, Tuel RJ, Labarbera M, Greenwald DP (1993) Effects of constant mechanical tension on the healing of rabbit flexor tendons. Clin Orthop Relat Res 296:301–306PubMedGoogle Scholar
  12. 12.
    Mass DP, Tuel RJ (1990) Participation of human superficialis flexor tendon segments in repair in vitro. J Orthop Res 8:21–34PubMedGoogle Scholar
  13. 13.
    Fenwick SA, Hazleman BL, Riley GP (2002) The vasculature and its role in the damaged and healing tendon. Arthritis Res 4:252–260PubMedCentralPubMedGoogle Scholar
  14. 14.
    Pufe T, Petersen WJ, Mentlein R, Tillmann BN (2005) The role of vasculature and angiogenesis for the pathogenesis of degenerative tendon disease. Scand J Med Sci Sports 15:211–222PubMedGoogle Scholar
  15. 15.
    Paoloni J, De Vos RJ, Hamilton B, Murrell GA, Orchard J (2011) Platelet-rich plasma treatment for ligament and tendon injuries. Clin J Sport Med 21:37–45PubMedGoogle Scholar
  16. 16.
    Murray MM, Spindler KP, Ballard P, Welch TP, Zurakowski D, Nanney LB (2007) Enhanced histologic repair in a central wound in the anterior cruciate ligament with a collagen-platelet-rich plasma scaffold. J Orthop Res 25:1007–1017PubMedGoogle Scholar
  17. 17.
    Khan KM, Cook JL, Bonar F, Harcourt P, Astrom M (1999) Histopathology of common tendinopathies. Update and implications for clinical management. Sports Med 27:393–408PubMedGoogle Scholar
  18. 18.
    Hayler CI, Guffre BM (2009) Overuse of isolated and multiple ligament injuries of the elbow. Magn Reson Imaging Clin N Am 17:617–638Google Scholar
  19. 19.
    Yastrebov O, Lobenhoffer I (2009) Treatment of isolated and multiple ligament injuries of the knee: anatomy, biomechanics, diagnosis, indications for repair, surgery. Othopade 38:563–580Google Scholar
  20. 20.
    Yoon JH, Halper J (2005) Tendon proteoglycans: biochemistry and function. J Musculoskelet Neuronal Interact 5(1):22–34PubMedGoogle Scholar
  21. 21.
    Frank C, McDonla D, Shrive N (1997) Collagen fibril diameters in the rabbit medial collateral ligament scar. Connect Tissue Res 36:261–269PubMedGoogle Scholar
  22. 22.
    Halper J (2010) Growth factors as active participants in carcinogenesis: a perspective. Vet Pathol 47:77–97PubMedGoogle Scholar
  23. 23.
    Molloy T, Wang Y, Murrell G (2003) The roles of growth factors in tendon and ligament healing. Sports Med 33:381–394PubMedGoogle Scholar
  24. 24.
    Connolly EC, Freimuth J, Akhurst RJ (2012) Complexities of TGF-β targeted cancer therapy. Int J Biol Sci 8:964–978PubMedCentralPubMedGoogle Scholar
  25. 25.
    Hinck AP (2012) Structural studies of the TGF-bs and their receptors – insights into evolution of the TGF-b superfamily. FEBS Lett 586:1860–1870PubMedGoogle Scholar
  26. 26.
    Massague J, Wotton D (2000) Transcriptional control by the TGF-beta/Smad signaling system. Embo J 19:1745–1754PubMedGoogle Scholar
  27. 27.
    Cai J, Pardali E, Sánchez-Duffhues G, ten Dijke P (2012) BMP signaling in vascular diseases. FEBS Lett 586:1993–2002PubMedGoogle Scholar
  28. 28.
    Kingsley DM (1994) The TGFβ superfamily: new members, new receptors, and new genetic tests of function on different organisms. Genes Dev 8:133–146PubMedGoogle Scholar
  29. 29.
    O’kane S, Ferguson MWJ (1997) Transforming growth factor βs and wound healing. Int J Biochem Cell Biol 29:63–78PubMedGoogle Scholar
  30. 30.
    Lincoln J, Lange AW, Yutzey KE (2006) Hearts and bones: shared regulatory mechanisms in heart valve, cartilage, tendon, and bone development. Dev Biol 294:292–302PubMedGoogle Scholar
  31. 31.
    Dickson MC, Martin JS, Cousins FM, Kulkarni AB, Karlsson S, Akhurst RJ (1995) Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Development 121:1845–1854PubMedGoogle Scholar
  32. 32.
    Kruithof BPT, Duim SN, Moerkamp AT, Goumans MJ (2012) TGFβ and BMP signaling in cardiac cushion formation: lessons from mice and chicken. Differentiation 84:89–102PubMedGoogle Scholar
  33. 33.
    Zhang H, Bradley A (1996) Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development 122:2977–2986PubMedGoogle Scholar
  34. 34.
    Goumans MJ, Mummery C (2000) Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice. Int J Dev Biol 44:253–265PubMedGoogle Scholar
  35. 35.
    Dahlgren LA, Mohammed HO, Nixon AJ (2005) Temporal expression of growth factors and matrix molecules in healing tendon lesions. J Orthop Res 23:84–92PubMedGoogle Scholar
  36. 36.
    Hou Y, Mao ZB, Wei XL, Lin L, Chen LX, Wang HJ, Fu X, Zhang JY, Yu C (2009) Effects of transforming growth factor-β1 and vascular endothelial growth factor 165 gene transfer on Achilles tendon healing. Matrix Biol 28:324–335PubMedGoogle Scholar
  37. 37.
    Heisterbach PE, Todorov A, Flückiger R, Evans CH, Majewski M (2011) Effect of BMP-12, TGF-β1 and autologous conditioned serum on growth factor expression in Achilles tendon healing. Knee Surg Sports Traumatol Arthrosc 20:1907–1914PubMedGoogle Scholar
  38. 38.
    Azuma C, Tohyama H, Nakamura H, Kanaya F, Yasuda K (2007) Antibody neutralization of TGF-β enhances the deterioration of collagen fascicles in a tissue-cultured tendon matrix with ex vivo fibroblast infiltration. J Biomech 40:2184–2190PubMedGoogle Scholar
  39. 39.
    Majewski M, Porter RM, Betz OB, Betz VM, Clahsen H, Flückiger R, Evans CH (2012) Improvement of tendon repair using muscle grafts transduced with TGF-β1 cDNA. Eur Cell Mater 23:94–101PubMedGoogle Scholar
  40. 40.
    Nixon AJ, Watts AE, Schnabel LV (2012) Cell- and gene-based approaches to tendon regeneration. J Shoulder Elbow Surg 21:278–294PubMedGoogle Scholar
  41. 41.
    Chang J, Thunder R, Most D, Longaker MT, Lineaweaver WC (2000) Studies in flexor tendon wound healing: neutralizing antibody to TGF-beta1 increases postoperative range of motion. Plast Reconstr Surg 105:148–155PubMedGoogle Scholar
  42. 42.
    Chang J, Most D, Stelnicki E, Siebert JW, Longaker MT, Hui K, Lineaweaver WC (1997) Gene expression of transforming growth factor beta-1 in rabbit zone II flexor tendon wound healing: evidence for dual mechanisms of repair. Plast Reconstr Surg 100:937–944PubMedGoogle Scholar
  43. 43.
    Urist MR (1965) Bone: formation by autoinduction. Science 150:893–890PubMedGoogle Scholar
  44. 44.
    Guo J, Wu G (2012) The signaling and functions of heterodimeric bone morphogenetic proteins. Cytokine Growth Factor Rev 23:61–67PubMedGoogle Scholar
  45. 45.
    Miyazono K, Maeda S, Imamura T (2005) BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev 16:251–263PubMedGoogle Scholar
  46. 46.
    King JA, Storm EE, Marker PC, Dileone RJ, Kingsley DM (1996) The role of BMPs and GDFs in development of region-specific skeletal structures. Ann N Y Acad Sci 785:70–79PubMedGoogle Scholar
  47. 47.
    Wang EA, Rosen V, Cordes P, Hewick RM, Kriz MJ, Luxenberg DP, Sibley BS, Wozney JM (1988) Purification and characterization of other distinct bone-inducing factors. Proc Natl Acad Sci U S A 85:9484–9488PubMedCentralPubMedGoogle Scholar
  48. 48.
    Aspenberg P, Forslund C (1999) Enhanced tendon healing with GDF 5 and 6. Acta Orthop Scand 70:51–54PubMedGoogle Scholar
  49. 49.
    D’Souza D, Patel K (1999) Involvement of long- and short-range signaling during early tendon development. Anat Embryol (Berl) 200:367–375Google Scholar
  50. 50.
    Lee JY, Zhou Z, Taub PJ, Ramcharan M, Li Y, Akinbiyi T, Maharam ER, Leong DJ, Laudier DM, Ruike T, Torina PJ, Zaidi M, Majeska RJ, Schaffler MB, Flatow EL, Sun HB (2011) BMP-12 treatment of adult mesenchymal stem cells in vitro augments tendon-like tissue formation and defect repair in vivo. PLoS One 6:e17531PubMedCentralPubMedGoogle Scholar
  51. 51.
    Wolfman NM, Hattersley G, Cox A, Celeste AJ, Nelson R, Yamaji N, Dube JL, DiBlasio-Smith E, Nove J, Song JJ, Wozney JM, Rosen V (1997) Ectopic induction of tendon and ligament in rats by growth and differentiation factors 5, 6, and 7, members of the TGF-β gene family. J Clin Invest 100:321–330PubMedCentralPubMedGoogle Scholar
  52. 52.
    Forslund C, Rueger D, Aspenberg P (2003) A comparative dose-response study of cartilage-derived morphogenetic protein (CDMP)-1, -2 and -3 for tendon healing in rats. J Orthop Res 21:617–621PubMedGoogle Scholar
  53. 53.
    Dines JC, Weber L, Razzano P, Prajapati R, Timmer M, Bowman S, Bonasser L, Dines DM, Grande DP (2007) The effect of growth differentiation factor-5 coated sutures on tendon repair in a rat model. J Shoulder Elbow Surg 16:S215–S225PubMedGoogle Scholar
  54. 54.
    Bolt P, Clerk AN, Luu HH, Kang Q, Kummer JL, Deng ZL, Olson K, Primus F, Montag AG, He TV, Haydon RC, Toolan BC (2007) BMP-14 gene therapy increases tendon tensile strength in a rat model of Achilles tendon injury. J Bone Joint Surg Am 89:1315–1320PubMedGoogle Scholar
  55. 55.
    Tan SL, Ahmad RE, Ahmad TS, Merican AM, Abbas AA, Ng WM, Kamarul T (2012) Effect of growth differentiation factor 5 on the proliferation and tenogenic differentiation potential of human mesenchymal stem cells in vitro. Cells Tissues Organs 196:325–338PubMedGoogle Scholar
  56. 56.
    Moore YR, Dickinson DP, Wikesjö UME (2010) Growth/differentiation factor-5: a candidate therapeutic agent for periodontal regeneration? A review of pre-clinical data. J Clin Periodontol 37:288–298PubMedGoogle Scholar
  57. 57.
    Helm GA, Li JZ, Alden TD, Hudson SB, Beres EJ, Cunningham M, Mikkelsen MM, Pittman DD, Kerns KM, Kallmes DF (2001) A light and electron microscopic study of ectopic tendon and ligament formation induced by bone morphogenetic protein–13 adenoviral gene therapy. J Neurosurg 95:298–307PubMedGoogle Scholar
  58. 58.
    Lou J, Tu Y (2001) BMP-12 gene transfer augmentation of lacerated tendon repair. J Orthop Res 19:1199–1202PubMedGoogle Scholar
  59. 59.
    Wang QW, Chen ZL, Piao YJ (2005) Mesenchymal stem cells differentiate into tenocytes by bone morphogenetic protein (BMP) 12 gene transfer. J Biosci Bioeng 100:418–422PubMedGoogle Scholar
  60. 60.
    Violini S, Ramelli P, Pisani LF, Gorni C, Mariani P (2009) Horse bone marrow mesenchymal stem cells express embryo stem cell markers and show the ability for tenogenic differentiation by in vitro exposure to BMP-12. BMC Cell Biol 10:29PubMedCentralPubMedGoogle Scholar
  61. 61.
    Forslund C, Aspenberg P (2002) CDMP-2 induces bone or tendon-like tissue depending on mechanical stimulation. J Orthop Res 20:1170–1174PubMedGoogle Scholar
  62. 62.
    Starman JS, Bosse MJ, Cates CA, Norton HJ (2012) Recombinant human bone morphogenetic protein-2 use in the off-label treatment of nonunions and acute fractures: a retrospective review. J Traumatol Acute Care Surg 72:676–681Google Scholar
  63. 63.
    Hoffmann A, Pelled G, Turgeman G, Eberle P, Zilberman Y, Shinar H, Keinan-Adamsky K, Winkel A, Shahab S, Navon G, Gross G, Gazit D (2006) Neotendon formation induced by manipulation of the Smad8 signalling pathway in mesenchymal stem cells. J Clin Invest 116:940–952PubMedCentralPubMedGoogle Scholar
  64. 64.
    Rodeo SA, Suzuki K, Deng XH, Wozney J, Warren RF (1999) Use of recombinant human bone morphogenetic protein-2 to enhance tendon healing in a bone tunnel. Am J Sports Med 27:476–488PubMedGoogle Scholar
  65. 65.
    Thomopoulos S, Kim HM, Silva MJ, Ntouvali E, Manning CN, Potter R, Seeherman H, Gelberman RH (2012) Effect of bone morphogenetic protein 2 on tendon-to-bone healing in a canine flexor tendon model. J Orthop Res 30:1702–1709PubMedCentralPubMedGoogle Scholar
  66. 66.
    Macias D, Ganan Y, Sampath TK, Piedra ME, Ros MA, Hurle JM (1997) Role of BMP-2 and OP-1 (BMP-7) in programmed cell death and skeletogenesis during chick limb development. Development 124:1109–1117PubMedGoogle Scholar
  67. 67.
    Klatte-Schulz F, Pauly S, Scheibel M, Greiner S, Gerhardt C, Schmidmaier G, Wildemann B (2012) Influence of age on the cell biological characteristics and the stimulation potential of male human tenocyte-like cells. Eur Cell Mater 24:74–89PubMedGoogle Scholar
  68. 68.
    Nishimura R, Hata K, Matsubara T, Wakabayashi M, Yoneda T (2012) Regulation of bone and cartilage development by network between BMP signalling and transcription factors. J Biochem 151:247–254PubMedGoogle Scholar
  69. 69.
    Bell DM, Leung KK, Wheatley SC, Ng LJ, Zhou S, Ling KW, Sham MH, Koopman P, Tam PP, Cheah KS (1997) SOX9 directly regulates the type-II collagen gene. Nat Genet 16:174–178PubMedGoogle Scholar
  70. 70.
    Chimal-Monroy J, Rodriguez-Leon J, Montero JA, Ganan Y, Macias D, Merino R, Hurle JM (2003) Analysis of the molecular cascade responsible for mesodermal limb chondrogenesis: sox genes and BMP signaling. Dev Biol 257:292–301PubMedGoogle Scholar
  71. 71.
    Kou I, Ikegawa S (2004) SOX9-dependent and -independent transcriptional regulation of human cartilage link protein. J Biol Chem 279:50942–50948PubMedGoogle Scholar
  72. 72.
    Lefebvre V, Huang W, Harley VR, Goodfellow PN, de Crombrugghe B (1997) SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol Cell Biol 17:2336–2346PubMedCentralPubMedGoogle Scholar
  73. 73.
    Lincoln J, Alfieri CM, Yutzey KE (2006) BMP and FGF regulatory pathways control cell lineage diversification of heart valve precursor cells. Dev Biol 292:290–302Google Scholar
  74. 74.
    Zhao B, Etter L, Hinton RB Jr, Benson DW (2007) BMP and FGF regulatory pathways in semilunar valve precursor cells. Dev Dyn 236:971–980PubMedGoogle Scholar
  75. 75.
    Böttcher RT, Niehrs C (2005) Fibroblast growth factor signaling during early vertebrate development. Endocr Rev 26:63–77PubMedGoogle Scholar
  76. 76.
    Coutu DL, Galipeau J (2011) Roles of FGF signaling in stem cell self-renewal, senescence and aging. Aging 3:920–933PubMedCentralPubMedGoogle Scholar
  77. 77.
    Kosaka N, Sakamoto H, Terada M, Ochiya T (2009) Pleiotropic function of FGF-4: its role in development and stem cells. Dev Dyn 238:265–276PubMedGoogle Scholar
  78. 78.
    Beenken A, Mohammadi M (2009) The FGF family: biology, pathophysiology and therapy. Nat Rev Drug Discov 8:235–253PubMedCentralPubMedGoogle Scholar
  79. 79.
    Volk T (1999) Singling out Drosophila tendon cells: a dialogue between two distinct cell types. Trends Genet 15:448–453PubMedGoogle Scholar
  80. 80.
    Kieny M, Chevallier A (1979) Autonomy of tendon development in the embryonic chick wing. J Embryol Exp Morphol 49:153–165PubMedGoogle Scholar
  81. 81.
    Taylor GP, Anderson R, Reginelli AD, Muneola K (1994) FGF-2 induces regeneration of the chick limb bud. Dev Biol 163:282–284PubMedGoogle Scholar
  82. 82.
    Ker ED, Chu B, Phillippi JA, Gharaibeh B, Huard J, Weiss LE, Campbell PG (2011) Engineering spatial control of multiple differentiation fates within a stem cell population. Biomaterials 32:3413–3422PubMedCentralPubMedGoogle Scholar
  83. 83.
    Salingcarnboriboon RYH, Tsuji K, Obinata M, Amagasa T, Nifuji A, Noda M (2003) Establishment of tendon-derived cell lines exhibiting pluripotent mesenchymal stem cell-like property. Exp Cell Res 287:289–300PubMedGoogle Scholar
  84. 84.
    Ide J, Kikukawa K, Hirose J, Iyama KI, Sakamoto H, Eng DR, Fujimoto T, Mizuta H (2009) The effect of a local application of fibroblast growth factor-2 on tendon-to-bone remodeling in rats with acute injury and repair of the supraspinatus tendon. J Shoulder Elbow Surg 18:391–398PubMedGoogle Scholar
  85. 85.
    Taira M, Yoshida T, Miyagawa K, Sakamoto H, Terada M, Sugimura T (1987) cDNA sequence of human transforming gene hst and identification of the coding sequence required for transforming activity. Proc Natl Acad Sci U S A 84:2980–2984PubMedCentralPubMedGoogle Scholar
  86. 86.
    Yoshida T, Miyagawa K, Odagiri H, Sakamoto H, Little PF, Terada M, Sugimura T (1987) Genomic sequence of hst, a transforming gene encoding a protein homologous to fibroblasts growth factors and the int-2-encoded proteins. Proc Natl Acad Sci U S A 84:7305–7309PubMedCentralPubMedGoogle Scholar
  87. 87.
    Kelley KM, Schmidt KE, Berg L, Sak K, Galima MM, Gillespie C, Balogh L, Hawayek A, Reyes JA, Jamison M (2002) Comparative endocrinology of the insulin-like growth factor-binding protein. J Endocrinol 175:3–18PubMedGoogle Scholar
  88. 88.
    Messier C, Teutenberg K (2005) The role of insulin, insulin-like growth factor, and insulin-degrading enzyme in brain aging and Alzheimer’s disease. Neural Plast 12:311–328PubMedCentralPubMedGoogle Scholar
  89. 89.
    Jones JI, Clemmons DR (1995) Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3–34PubMedGoogle Scholar
  90. 90.
    Tsuzaki M, Brigman BE, Yamamoto J, Lawrence WT, Simmons JG, Mohapatra NK, Lund PK, Van Wyk J, Hannafin JA, Bhargava MM, Banes AJ (2000) Insulin-like growth factor-I is expressed by avian flexor tendon cells. J Orthop Res 18:546–556PubMedGoogle Scholar
  91. 91.
    Brown CA, Halper J (1990) Mitogenic effects of transforming growth factor type e on epithelial and fibroblastic cells–comparison with other growth factors. Exp Cell Res 190(2):233–242PubMedGoogle Scholar
  92. 92.
    Juul A (2003) Serum levels of insulin-like growth factor I and its binding protein in health and disease. Growth Horm IGF Res 13:113–120PubMedGoogle Scholar
  93. 93.
    Cheatham B, Kahn CR (1995) Insulin action and the insulin signalling network. Endocr Rev 16:117–142PubMedGoogle Scholar
  94. 94.
    LeRoith D, Werner H, Beitner JD, Roberts CJ (1995) Molecular and cellular aspects of the insulin-like factor I receptor. Endocr Rev 16:143–163PubMedGoogle Scholar
  95. 95.
    Hansson HA, Dahlin LB, Lundborg G, Löwenadler B, Paleus S, Skottner A (1988) Transiently increased insulin-like growth factor I immunoreactivity in tendons after vibration trauma: an immunohistochemical study on rats. Scand J Plast Reconstr Surg Hand Surg 22:1–6PubMedGoogle Scholar
  96. 96.
    Hansson HA, Engström AM, Holm S, Rosenqvist AL, Somatomedin C (1988) immunoreactivity in the Achilles tendon varies in a dynamic manner with the mechanical load. Acta Physiol Scand 134:199–208PubMedGoogle Scholar
  97. 97.
    Hansen M, Boesen A, Holm L, Flyvbjerg A, Landberg H, Kjaer M (2012) Local administration of insulin-like growth factor-I (IGF-I) stimulates tendon collagen synthesis in humans. Scand J Sports Med 23:614–619Google Scholar
  98. 98.
    Banes AJ, Tsuzaki M, Hu P, Brigman B, Brown T, Almekinders L, Lawrence WT, Fischer T (1995) PDGF-BB, IGF-I and mechanical load stimulate DNA synthesis in avian tendon fibroblasts in vitro. J Biomech 28:1505–1513PubMedGoogle Scholar
  99. 99.
    Heinemeier KM, Mackey AL, Doessing S, Hansen M, Bayer ML, Nielsen RH, Herchenhan A, Malmgaard-Clausen NM, Kjaer M (2012) GH/IGF-I axis and matrix adaptation of the musculotendinous tissue to exercise in humans. Scand J Med Sci Sports 22:e1–e7PubMedGoogle Scholar
  100. 100.
    Chetty A, Cao GJ, Nielsen HC (2006) Insulin-like growth factor signaling mechanisms, type I collagen and alpha smooth muscle actin in human fetal lung fibroblasts. Pediatr Res 60:389–394PubMedGoogle Scholar
  101. 101.
    Svegliati-Baroni G, Ridolfi F, Di SA, Casini A, Marucci L, Gaggiotti G, Orlandoni P, Macarri G, Perego L, Benedetti A, Folli F (1999) Insulin and insulin-like growth factor-I stimulate proliferation and type I accumulation by hepatic stellate cells; differential effects on signal transduction pathways. Hepatology 29:1743–1751PubMedGoogle Scholar
  102. 102.
    Ghahary A, Tredget EE, Shen Q, Kilani RT, Scott PG, Houle Y (2000) Mannose-6-phosphate/IGF-II receptors mediate the effects of IGF-I induced latent transforming growth factor beta 1 on expression of type I collagen and collagenase in dermal fibroblasts. Growth Factors 17:167–176PubMedGoogle Scholar
  103. 103.
    Andersson T, Eliasson P, Apenberg P (2012) Growth hormone does not stimulate early healing in rat tendons. Int J Sports Med 33:24–243Google Scholar
  104. 104.
    Provenzano PP, Alejandro-Osorio AL, Grorud KW, Martinez DA, Vailas AC, Grindenland RE, Vanderby R Jr (2001) Systemic administration of IGF-I enhances healing in collagenous extracellular matrices: evaluation of loaded and unloaded ligaments. BMC Physiol 7:2Google Scholar
  105. 105.
    Yamaguchi AF, Fujikawa T, Shimada S, Kanbayashi I, Tateoka M, Soya H, Takeda H, Morita I, Matsubara K, Hirai T (2006) Muscle IGF-I Ea, MGF, and myostatin mRNA expressions after compensatory overload in hypophysectomized rats. Pflugers Arch 453:203–210PubMedGoogle Scholar
  106. 106.
    Dai Z, Wu F, Yeung EW, Li Y (2010) IGF-IEc expression, regulation and biological function in different tissues. Growth Horm IGF Res 20:275–281PubMedGoogle Scholar
  107. 107.
    McCoy G, Ashley W, Mander J, Yang SY, Williams N, Russell B, Goldspink G (1999) Expression of insulin growth factor-1 splice variants and structural genes in rabbit skeletal muscle induced by stretch and stimulation. J Physiol 516:583–592Google Scholar
  108. 108.
    Heinemeier KM, Olesen JL, Schjerling P, Haddad F, Langberg H, Baldwin KM, Kjaer M (2007) Short-term strength training and the expression of myostatin and IGF-I isoforms in rat muscle and tendon: differential effects of specific contraction types. J Appl Physiol 102:573–581PubMedGoogle Scholar
  109. 109.
    Heinemeier KM, Olesen JL, Haddad F, Schjerling P, Baldwin KM, Kjaer M (2009) Effect of unloading followed by reloading on expression of collagen and related growth factors in rat tendon and muscle. J Appl Physiol 106:178–186PubMedGoogle Scholar
  110. 110.
    Dahlgren LA, Mohammed HO, Nixon AJ (2006) Expression of insulin-like growth factor binding proteins in healing tendon lesions. J Orthop Res 24:183–192PubMedGoogle Scholar
  111. 111.
    Olesen JL, Heinemeier KM, Langberg H, Magnusson SP, Kjaer M (2006) Expression, content, and localization of insulin-like growth factor I in human Achilles tendon. Connect Tissue Res 37:200–206Google Scholar
  112. 112.
    Durgam SS, Stewart AA, Pondenis HC, Yates AC, Evans RB, Stewart MC (2012) Responses of equine tendon- and bone marrow–derived cells to monolayer expansion with fibroblast growth factor-2 and sequential culture with pulverized tendon and insulinlike growth factor-I. Am J Vet Res 73:162–170PubMedGoogle Scholar
  113. 113.
    Genovese RL (1993) Prognosis of superficial digital flexor tendon and suspensory ligament injuries. Proc Am Assoc Equine Pract 39:17–19Google Scholar
  114. 114.
    Peloso JG, Mundy GD, Cohen ND (1994) Prevalence of, and factors associated with musculoskeletal racing injuries of Thoroughbreds. J Am Vet Med Assoc 204:620–626PubMedGoogle Scholar
  115. 115.
    Murphy DJ, Nixon AJ (1997) Biochemical and site-specific effects of insulin-like growth factor I on intrinsic tenocyte activity in equine flexor tendons. Am J Vet Res 58:103–109PubMedGoogle Scholar
  116. 116.
    Durgam SS, Stewart AA, Pondenis HC, Gutierrez-Nibeyro SM, Yates AC, Evans RB, Stewart MC (2012) Comparison of equine tendon- and bone marrow–derived cells cultured on tendon matrix with or without insulin-like growth factor-I supplementation. Am J Vet Res 73:153–161PubMedGoogle Scholar
  117. 117.
    Dahlgren LA, va der Meulen MC, Bertram JE, Starrak GS, Nixon AJ (2002) Insulin-like growth factor-I improves cellular and molecular aspects of healing in a collagenase-induced model of flexor tendinitis. J Orthop Res 20:910–919PubMedGoogle Scholar
  118. 118.
    Witte TH, Yeager AE, Nixon AJ (2011) Intralesional injection of insulin-like growth factor-I for treatment of superficial digital flexor tendonitis in Thoroughbred racehorses: 40 cases (2000–2004). J Am Vet Med Assoc 239:992–997PubMedGoogle Scholar
  119. 119.
    Aspenberg P (2007) Stimulation of tendon repair: mechanical loading, GDFs and platelets. Int Orthop 31:783–789PubMedCentralPubMedGoogle Scholar
  120. 120.
    McDonald NQ, Hendrickson WA (1993) A structural superfamily of growth factors containing a cystine knot motif. Cell 73:421–424PubMedGoogle Scholar
  121. 121.
    Andrae J, Gallini R, Betsholtz C (2008) Role of platelet-derived growth factors in physiology and medicine. Genes Dev 22:1276–1312PubMedGoogle Scholar
  122. 122.
    Haupt JL, Donnelly BP, Nixon AJ (2006) Effects of platelet-derived growth factor-BB on the metabolic function and morphologic features of equine tendon in explant culture. Am J Vet Res 67:1595–1600PubMedGoogle Scholar
  123. 123.
    Aspenberg P, Virchenko O (2004) Platelet concentrate injection improves Achilles tendon repair in rats. Acta Orthop Scand 75:93–99PubMedGoogle Scholar
  124. 124.
    Stiles CD, Capone GT, Scher CD, Antoniades HN, Van Wyk JJ, Pledger WJ (1979) Dual control of cell growth by somatomedins and platelet-derived growth factor. Proc Natl Acad Sci U S A 76:1279–1283PubMedCentralPubMedGoogle Scholar
  125. 125.
    Suwalski A, Dabboue H, Delalande A, Bensamoun SF, Canon F, Midoux P, Saillant G, Klatzmann D, Salvetat JP, Pichon C (2010) Accelerated Achilles tendon healing by PDGF gene delivery with mesoporous silica nanoparticles. Biomaterials 31:5237–5245PubMedGoogle Scholar
  126. 126.
    Raja S, Byakod G, Pudakalkatti P (2009) Growth factors in periodontal regeneration. Int J Dent Hyg 7:82–89PubMedGoogle Scholar
  127. 127.
    Hildebrand KA, Woo SL, Smith DW, Allen CR, Deie M, Taylor BJ, Schmidt CC (1998) The effects of platelet-derived growth factor-BB on healing of the rabbit medial collateral ligament. An in vivo study. Am J Sports Med 26:549–554PubMedGoogle Scholar
  128. 128.
    Batten ML, Hansen JC, Dahners LE (1996) Influence of dosage and timing of application of platelet-derived growth factor on early healing of the rat medial collateral ligament. J Orthop Res 14:736–741PubMedGoogle Scholar
  129. 129.
    Roy V, Peretz EA (2009) Biologic therapy of breast cancer: focus on co-inhibition of endocrine and angiogenesis pathways. Breast Cancer Res Treat 116:31–38PubMedGoogle Scholar
  130. 130.
    Pufe T, Petersen WJ, Kurz B, Tsokos M, Tillmann BN, Mentlein R (2003) Mechanical factors influence the expression of endostatin – an inhibitor of angiogenesis - in tendons. J Orthop Res 21:610–616PubMedGoogle Scholar
  131. 131.
    Pufe T, Petersen W, Goldring MB, Mentlein R, Varoga D, Tsokos M, Tillmann B (2004) Endostatin – an inhibitor of angiogenesis – is expressed in human cartilage and fibrocartilage. Matrix Biol 23:267–276PubMedGoogle Scholar
  132. 132.
    Sahin H, Tholema N, Raschke MJ, Stange R (2012) Impaired biomechanical properties correlate with neoangiogenesis as well as VEGF and MMP-3 expression during rat patellar tendon healing. J Orthop Res 30(12):1952–1957PubMedGoogle Scholar
  133. 133.
    Savitskaya YA, Izaguirre A, Sierra L, Perez F, Cruz F, Villalobos E, Almazan A, Ibarra C (2011) Effect of angiogenesis-related cytokines on rotator cuff disease: the search for sensitive biomarkers of early tendon degeneration. Clin Med Insights Arthritis Musculoskelet Disord 4:43–53PubMedCentralPubMedGoogle Scholar
  134. 134.
    Hofer T, Desbaillets I, Höpfl G, Gassmann M, Wenger RH (2001) Dissecting hypoxia-dependent and hypoxia-independent steps in the HIF-1alpha activation cascade: implications for HIF-1alpha gene therapy. FASEB J 15:2715–2717PubMedGoogle Scholar
  135. 135.
    Pufe T, Kurz B, Petersen W, Varoga D, Mentlein R, Kulow S, Lemke A, Tillmann B (2005) The influence of biomechanical parameters on the expression of VEGF and endostatin in the bone and joint system. Ann Anat 187:461–472PubMedGoogle Scholar
  136. 136.
    Petersen W, Pufe T, Zantop T, Tillmann B, Tsokos M, Mentlein R (2004) Expression of VEGFR-1 and VEGFR-2 in degenerative Achilles tendon. Clin Orthop 420:286–291PubMedGoogle Scholar
  137. 137.
    Loiselle AE, Bragdon GA, Jacobson JA, Hasslund S, Cortes ZE, Schwarz EM, Mitten DJ, Awad HA, O’Keefe RJ (2009) Remodeling of murine intrasynovial tendon adhesions following injury: MMP and neotendon gene expression. J Orthop Res 27:833–840PubMedGoogle Scholar
  138. 138.
    Riley GP, Curry V, DeGroot J, van El B, Verzijl N, Hazleman BL, Bank RA (2002) Matrix metalloproteinase activities and their relationship with collagen remodeling in tendon pathology. Matrix Biol 21:185–195PubMedGoogle Scholar
  139. 139.
    Riley G (2008) Tendinopathy – from basic science to treatment. Nat Clin Pract Rheumatol 4:82–89PubMedGoogle Scholar
  140. 140.
    Ohberg L, Lorentzon R, Alfredson H (2001) Neovascularisation in Achilles tendons with painful tendinosis but not in normal tendons: an ultrasonographic investigation. Knee Surg Sports Traumatol Arthrosc 9:235–238Google Scholar
  141. 141.
    Corps AN, Jones GC, Harrall RL, Curry VA, Hazleman BL, Riley GP (2008) The regulation of aggrecanase ADAMTS-4 expression in human Achilles tendon and tendon-derived cells. Matrix Biol 27:393–401PubMedCentralPubMedGoogle Scholar
  142. 142.
    Lyras DN, Kazakos K, Veretas D, Chronopoulos E, Folaranmi S, Agrogiannis G (2010) Effect of combined administration of transforming growth factor-b1 and insulin-like growth factor I on the mechanical properties of a patellar tendon defect model in rabbits. Acta Orthop Belg 76:380–386PubMedGoogle Scholar
  143. 143.
    Raghavan SS, Woon CY, Kraus A, Megerle K, Pham H, Chang J (2012) Optimization of human tendon tissue engineering: synergistic effects of growth factors for use in tendon scaffold repopulation. Plast Reconstr Surg 129:479–489PubMedGoogle Scholar
  144. 144.
    Bachl N, Derman W, Engebretsen L, Goldspink G, Kinzlbauer M, Tschan H, Volpi P, Venter D, Wessner B (2009) Therapeutic use of growth factors in the musculoskeletal system in sports-related injuries. J Sports Med Phys Fitness 49:346–357PubMedGoogle Scholar
  145. 145.
    Hagerty P, Lee A, Calve S, Lee CA, Vidal M, Baar K (2012) The effect of growth factors on both collagen synthesis and tensile strength of engineered human ligaments. Biomaterials 33:6355–6361PubMedGoogle Scholar
  146. 146.
    Lyras DN, Kazakos K, Georgiadis G, Mazis G, Middleton R, Richards S, O’Connor D (2011) Does a single application of PRP alter the expression of IGF-I in the early phase of tendon healing? J Foot Ankle Surg 50:276–282PubMedGoogle Scholar
  147. 147.
    de Mos MWAE, Jahr H, van Schie HT, Weinans H, Verhaar JA, van Osch GJ (2008) Can platelet-rich plasma enhance tendon repair? A cell culture study. Am J Sports Med 36:1171–1178PubMedGoogle Scholar
  148. 148.
    Kim HJ, Nam HW, Hur CY, Park M, Yang HS, Kim BS, Park JH (2011) The effect of platelet rich plasma from bone marrow aspirate with added bone morphogenetic protein-2 on the Achilles tendon-bone junction in rabbits. Clin Orthop Surg 3:325–331PubMedCentralPubMedGoogle Scholar
  149. 149.
    Murray MM, Palmer M, Abreu E, Spindler KP, Zurakowski D, Fleming BC (2009) Platelet-rich plasma alone is not sufficient to enhance suture repair of the ACL in skeletally immature animals: an in vivo study. J Orthop Res 27:639–645PubMedCentralPubMedGoogle Scholar
  150. 150.
    Kaux JF, Drion PV, Colige A, Pascon F, Libertiaux V, Hoffmann A, Janssen L, Heyers A, Nusgens BV, Le Goff C, Gothot A, Cescotto S, Defraigne JO, Rickert M, Crielaard JM (2012) Effects of platelet-rich plasma (PRP) on the healing of Achilles tendons of rats. Wound Repair Regen 20:748–756PubMedGoogle Scholar
  151. 151.
    Bava ED, Barber FA (2011) Platelet-rich plasma products in sports medicine. Phys Sportsmed 39:94–95PubMedGoogle Scholar
  152. 152.
    Abate M, Di Gregorio P, Schiavone C, Salini V, Tosi U, Muttini A (2012) Platelet rich plasma in tendinopathies: how to explain the failure. Int J Immunopathol Pharmacol 25:325–334PubMedGoogle Scholar
  153. 153.
    Del Buono A, Papalia R, Denaro V, Maccauro G, Maffulli N (2011) Platelet rich plasma and tendinopathy: state of the art. Int J Immunopathol Pharmacol 24:79–83PubMedGoogle Scholar
  154. 154.
    Sharma RI, Snedeker JG (2010) Biochemical and biomechanical gradients for directed bone marrow stromal cell differentiation toward tendon and bone. Biomaterials 31:7695–7704PubMedGoogle Scholar
  155. 155.
    Sharma RI, Snedeker JG (2012) Paracrine interactions between mesenchymal stem cells affect substrate driven differentiation toward tendon and bone phenotypes. PLoS One 7:e31504PubMedCentralPubMedGoogle Scholar
  156. 156.
    Juncosa-Melvin N, Matlin KS, Holdcraft RW, Nirmalanandhan VS, Butler DL (2007) Mechanical stimulation increases collagen type I and collagen type III gene expression of stem cell-collagen sponge constructs for patellar tendon repair. Tissue Eng 13:1219–1226PubMedGoogle Scholar
  157. 157.
    Lovati AB, Corradetti B, Lange Consiglio A, Recordati C, Bonacina E, Bizzaro D, Cremonesi E (2011) Characterization and differentiation of equine tendon-derived progenitor cells. J Biol Regul Homeost Agents 25:S75–S84PubMedGoogle Scholar
  158. 158.
    Godwin EE, Young NJ, Dudhia J, Beamish IC, Smith RKW (2011) Implantation of bone marrow-derived mesenchymal stem cells demonstrates improved outcome in horses with overstrain injury of the superficial digital flexor tendon. Equine Vet J 44:25–32PubMedGoogle Scholar
  159. 159.
    Marfe G, Rotta G, De Martino L, Tafani M, Fiorito F, Di Stefano C, Polettini M, Ranalli M, Russo MA, Gambacurta A (2012) A new clinical approach: use of blood-derived stem cells (BDSCs) for superficial digital flexor tendon injuries in horses. Life Sci 90:825–830PubMedGoogle Scholar
  160. 160.
    Borjesson DL, Peroni JF (2011) The regenerative medicine laboratory: facilitating stem cell therapy for equine disease. Clin Lab Med 31:109–123PubMedGoogle Scholar
  161. 161.
    Kol AW, Walker NJ, Galuppo LD, Clark KC, Buerchler S, Bernanke A, Borjesson DL (2013) Autologous point-of-care cellular therapies variably induce equine mesenchymal stem cell migration, proliferation and cytokine expression. Equine Vet J 45:193–198PubMedGoogle Scholar
  162. 162.
    Caniglia CJ, Schramme MC, Smith RK (2012) The effect of intralesional injection of bone marrow derived mesenchymal stem cells and bone marrow supernatant on collagen fibril size in a surgical model of equine superficial digital flexor tendonitis. Equine Vet J 44:587–593PubMedGoogle Scholar
  163. 163.
    Uysal CA, Tobita M, Hyakusoku H, Mizuno H (2012) Adipose-derived stem cells enhance primary tendon repair: biomechanical and immunohistochemical evaluation. J Plast Reconstr Aesthet Surg 65:1712–1719PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2014

Authors and Affiliations

  1. 1.Department of Pathology, College of Veterinary Medicine and Medical PartnershipThe University of GeorgiaAthensUSA

Personalised recommendations